Literature DB >> 16881061

Notexin causes greater myotoxic damage and slower functional repair in mouse skeletal muscles than bupivacaine.

David R Plant1, Fiona E Colarossi, Gordon S Lynch.   

Abstract

Although the myotoxins bupivacaine and notexin are employed for studying processes that regulate muscle regeneration after injury, no studies have compared their efficacy in causing muscle damage or assessing functional regeneration in mouse skeletal muscles. Bupivacaine causes extensive injury in rat muscles but its effects on mouse muscles are variable. We compared functional and morphological properties of regenerating mouse extensor digitorum longus (EDL) muscles after notexin or bupivacaine injection and tested the hypothesis that muscle damage would be more extensive and functional repair less complete after notexin injection. Bupivacaine caused degeneration of 45% of fibers and reduced maximum force (Po) to 42% of control after 3 days. In contrast, notexin caused complete fiber breakdown and loss of functional capacity after 3 days (P < 0.05). At 7 and 10 days after bupivacaine, Po was restored to 65% and 71% of control, respectively, whereas Po of notexin-injected muscles was only 10% and 39% of control at these time-points, respectively (P < 0.05). At 7 and 10 days after bupivacaine, approximately 30% of fibers were centrally nucleated (regenerating), whereas notexin-injected muscles were comprised entirely of regenerating fibers (P < 0.05). The results demonstrate that notexin causes a more extensive and complete injury than bupivacaine, and is a useful model for studying muscle regeneration in mice.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16881061     DOI: 10.1002/mus.20616

Source DB:  PubMed          Journal:  Muscle Nerve        ISSN: 0148-639X            Impact factor:   3.217


  29 in total

1.  Guanidination of notexin alters its membrane-damaging activity in response to sphingomyelin and cholesterol.

Authors:  Pei-Hsiu Kao; Yi-Ling Chiou; Shinne-Ren Lin; Long-Sen Chang
Journal:  J Biosci       Date:  2010-12       Impact factor: 1.826

2.  Timed Delivery of Therapy Enhances Functional Muscle Regeneration.

Authors:  Christine A Cezar; Praveen Arany; Sarah A Vermillion; Bo Ri Seo; Herman H Vandenburgh; David J Mooney
Journal:  Adv Healthc Mater       Date:  2017-07-13       Impact factor: 9.933

3.  Fetal microchimeric cells in a fetus-treats-its-mother paradigm do not contribute to dystrophin production in serially parous mdx females.

Authors:  Elke Jane Seppanen; Samantha Susan Hodgson; Kiarash Khosrotehrani; George Bou-Gharios; Nicholas M Fisk
Journal:  Stem Cells Dev       Date:  2012-08-06       Impact factor: 3.272

4.  Differential effects of leucine supplementation in young and aged mice at the onset of skeletal muscle regeneration.

Authors:  Richard A Perry; Lemuel A Brown; David E Lee; Jacob L Brown; Jamie I Baum; Nicholas P Greene; Tyrone A Washington
Journal:  Mech Ageing Dev       Date:  2016-06-18       Impact factor: 5.432

Review 5.  Biotoxins in muscle regeneration research.

Authors:  Mohamed A A Mahdy
Journal:  J Muscle Res Cell Motil       Date:  2019-07-29       Impact factor: 2.698

6.  Alternative splicing dysregulation secondary to skeletal muscle regeneration.

Authors:  James P Orengo; Amanda J Ward; Thomas A Cooper
Journal:  Ann Neurol       Date:  2011-03-11       Impact factor: 10.422

7.  Hyaluronan synthesis and myogenesis: a requirement for hyaluronan synthesis during myogenic differentiation independent of pericellular matrix formation.

Authors:  Liam C Hunt; Chris Gorman; Christopher Kintakas; Daniel R McCulloch; Eleanor J Mackie; Jason D White
Journal:  J Biol Chem       Date:  2013-03-14       Impact factor: 5.157

8.  Modulation of insulin-like growth factor (IGF)-I and IGF-binding protein interactions enhances skeletal muscle regeneration and ameliorates the dystrophic pathology in mdx mice.

Authors:  Jonathan D Schertzer; Stefan M Gehrig; James G Ryall; Gordon S Lynch
Journal:  Am J Pathol       Date:  2007-09-06       Impact factor: 4.307

Review 9.  Myotoxicity of injections for acute muscle injuries: a systematic review.

Authors:  Gustaaf Reurink; Gert Jan Goudswaard; Maarten H Moen; Adam Weir; Jan A N Verhaar; Johannes L Tol
Journal:  Sports Med       Date:  2014-07       Impact factor: 11.136

10.  Attenuated muscle regeneration is a key factor in dysferlin-deficient muscular dystrophy.

Authors:  Yen-Hui Chiu; Mark A Hornsey; Lars Klinge; Louise H Jørgensen; Steven H Laval; Richard Charlton; Rita Barresi; Volker Straub; Hanns Lochmüller; Kate Bushby
Journal:  Hum Mol Genet       Date:  2009-03-13       Impact factor: 6.150

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.